03-05-2013

Ben-Gurion University of the Negev researchers have proven that chronic stress increases the susceptibility to an autoimmune disease similar to multiple sclerosis, which is characterized by damage to the nervous system in the brain. The researchers, Dr. Idan Harpaz and Prof. Alon Monsonego, ...

more

University of Leicester leads team studying telomere length in chromosomes

02-04-2013

An international team of scientists led by the University of Leicester has found new evidence that links faster 'biological' ageing to the risk of developing several age-related diseases - including heart disease, multiple sclerosis and various cancers. The study involved scientists in 14 ...

more

08-03-2013

People with multiple sclerosis (MS) who have cognitive problems, or problems with memory, attention, and concentration, have more damage to areas of the brain involved in cognitive processes than people with MS who do not have cognitive problems, according to a study published in the issue of ...

more

Feb. 15 is International Angelman Day

14-02-2013

In a new study in mice, a scientific collaboration centered at Brown University lays out in unprecedented detail a neurological signaling breakdown in Angelman syndrome, a disorder that affects thousands of children each year, characterized by developmental delay, seizures, and other ...

more

23-08-2012

New magnetic resonance imaging (MRI) research shows that changes in brain blood flow associated with vein abnormalities are not specific for multiple sclerosis (MS) and do not contribute to its severity, despite what some researchers have speculated. Results of the research are published in ...

more

Researchers identify potassium channel as an autoantibody target

17-07-2012

Diagnosing multiple sclerosis (MS) is a challenge even for experienced neurologists. This autoimmune disease has many symptoms and rarely presents a uniform clinical picture. New scientific findings on the immune response involved in MS could now help improve the diagnosis of this illness. ...

more

14-06-2012

A receptor recently discovered to control the movement of immune cells across central nervous system barriers (including the blood-brain barrier) may hold the key to treating multiple sclerosis (MS).In MS, immune cells enter the central nervous system and attack and destroy the myelin sheath ...

more

04-06-2012

Genzyme, a Sanofi company, announced top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis (MS). In the ...

more

Synthon intends to defend vigorously

10-04-2012

Synthon has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for glatiramer acetate, 20 mg/ml solution for injection in pre-filled syringes. The reference listed drug for glatiramer acetate is Copaxone, indicated for reduction of the frequency of ...

more

Emergence of Innovative Treatment Options to Support Improved Compliance and Enhanced Therapeutic Results

15-03-2012

Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis (MS) market. This is being exacerbated by the limited availability of accurate diagnostic tools. There is, therefore, an immediate need for innovative ...

more